Annual Total Assets
$1.63 M
+$182.00 K+12.61%
31 December 2022
Summary:
Nymox Pharmaceutical annual total assets is currently $1.63 million, with the most recent change of +$182.00 thousand (+12.61%) on 31 December 2022. During the last 3 years, it has fallen by -$2.72 million (-62.58%).NYMX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$575.00 K
-$1.05 M-64.62%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly total assets is currently $575.00 thousand, with the most recent change of -$1.05 million (-64.62%) on 31 March 2023.NYMX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -62.6% | -85.1% |
| 5 y5 years | -79.9% | -92.3% |
NYMX Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -88.0% | -95.7% |
Nymox Pharmaceutical Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $575.00 K(-64.6%) |
| Dec 2022 | $1.63 M(+12.6%) | $1.63 M(-48.3%) |
| Sept 2022 | - | $3.14 M(-29.8%) |
| June 2022 | - | $4.47 M(+261.4%) |
| Mar 2022 | - | $1.24 M(-14.2%) |
| Dec 2021 | $1.44 M(-66.8%) | $1.44 M(-62.5%) |
| Sept 2021 | - | $3.85 M(-42.3%) |
| June 2021 | - | $6.67 M(+358.4%) |
| Mar 2021 | - | $1.46 M(-66.5%) |
| Dec 2020 | $4.34 M(-20.9%) | $4.34 M(-24.3%) |
| Sept 2020 | - | $5.74 M(+444.1%) |
| June 2020 | - | $1.05 M(-68.7%) |
| Mar 2020 | - | $3.37 M(-38.6%) |
| Dec 2019 | $5.49 M(-32.0%) | $5.49 M(-26.4%) |
| Sept 2019 | - | $7.46 M(-21.6%) |
| June 2019 | - | $9.52 M(-19.4%) |
| Mar 2019 | - | $11.80 M(+46.1%) |
| Dec 2018 | $8.08 M(+724.9%) | $8.08 M(+69.0%) |
| Sept 2018 | - | $4.78 M(-7.5%) |
| June 2018 | - | $5.17 M(+441.5%) |
| Mar 2018 | - | $954.00 K(-2.6%) |
| Dec 2017 | $979.00 K(-52.4%) | $979.00 K(-45.7%) |
| Sept 2017 | - | $1.80 M(+36.2%) |
| June 2017 | - | $1.32 M(-22.5%) |
| Mar 2017 | - | $1.71 M(-17.0%) |
| Dec 2016 | $2.06 M(+188.9%) | $2.06 M(+25.2%) |
| Sept 2016 | - | $1.64 M(+306.8%) |
| June 2016 | - | $403.90 K(-61.0%) |
| Mar 2016 | - | $1.04 M(+45.4%) |
| Dec 2015 | $712.00 K(-50.0%) | $712.00 K(+6.4%) |
| Sept 2015 | - | $669.40 K(-48.0%) |
| June 2015 | - | $1.29 M(+53.9%) |
| Mar 2015 | - | $836.10 K(-41.2%) |
| Dec 2014 | $1.42 M(+47.2%) | $1.42 M(+49.4%) |
| Sept 2014 | - | $952.20 K(+20.8%) |
| June 2014 | - | $788.20 K(-10.3%) |
| Mar 2014 | - | $879.00 K(-9.0%) |
| Dec 2013 | $966.40 K(-44.9%) | $966.40 K(-8.1%) |
| Sept 2013 | - | $1.05 M(-22.7%) |
| June 2013 | - | $1.36 M(-40.3%) |
| Mar 2013 | - | $2.28 M(+30.0%) |
| Dec 2012 | $1.75 M(-72.5%) | $1.75 M(-17.9%) |
| Sept 2012 | - | $2.14 M(-21.5%) |
| June 2012 | - | $2.72 M(-26.8%) |
| Mar 2012 | - | $3.72 M(-41.7%) |
| Dec 2011 | $6.38 M(-52.8%) | $6.38 M(-2.2%) |
| Sept 2011 | - | $6.52 M(-13.9%) |
| June 2011 | - | $7.57 M(-24.4%) |
| Mar 2011 | - | $10.02 M(-25.8%) |
| Dec 2010 | $13.50 M | $13.50 M(+1464.7%) |
| Sept 2010 | - | $862.90 K(+4.8%) |
| June 2010 | - | $823.50 K(-26.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $1.12 M(+3.2%) |
| Dec 2009 | $1.09 M(+45.4%) | $1.09 M(-25.6%) |
| Sept 2009 | - | $1.47 M(+34.2%) |
| June 2009 | - | $1.09 M(+28.7%) |
| Mar 2009 | - | $848.60 K(+13.2%) |
| Dec 2008 | $749.90 K(-82.4%) | $749.90 K(-82.2%) |
| Sept 2008 | - | $4.22 M(-0.0%) |
| June 2008 | - | $4.22 M(-7.4%) |
| Mar 2008 | - | $4.56 M(+7.0%) |
| Dec 2007 | $4.26 M(+7.3%) | $4.26 M(-0.8%) |
| Sept 2007 | - | $4.30 M(-12.8%) |
| June 2007 | - | $4.92 M(+13.6%) |
| Mar 2007 | - | $4.34 M(+9.2%) |
| Dec 2006 | $3.97 M(+6.8%) | $3.97 M(+6.3%) |
| Sept 2006 | - | $3.73 M(+1.1%) |
| June 2006 | - | $3.69 M(-19.5%) |
| Mar 2006 | - | $4.59 M(+23.4%) |
| Dec 2005 | $3.72 M(-8.5%) | $3.72 M(-0.8%) |
| Sept 2005 | - | $3.75 M(+1.6%) |
| June 2005 | - | $3.69 M(+0.4%) |
| Mar 2005 | - | $3.67 M(-9.6%) |
| Dec 2004 | $4.07 M(+1.6%) | $4.07 M(+1.7%) |
| Sept 2004 | - | $4.00 M(+0.1%) |
| June 2004 | - | $3.99 M(+3.0%) |
| Mar 2004 | - | $3.88 M(-3.1%) |
| Dec 2003 | $4.00 M(-8.2%) | $4.00 M(-6.7%) |
| Sept 2003 | - | $4.29 M(+14.3%) |
| June 2003 | - | $3.75 M(-13.0%) |
| Mar 2003 | - | $4.31 M(-1.0%) |
| Dec 2002 | $4.36 M(+4.0%) | $4.36 M(+8.5%) |
| Sept 2002 | - | $4.02 M(-4.7%) |
| June 2002 | - | $4.22 M(-11.1%) |
| Mar 2002 | - | $4.74 M(+13.1%) |
| Dec 2001 | $4.19 M(-4.4%) | $4.19 M(-9.3%) |
| Sept 2001 | - | $4.62 M(+5.5%) |
| June 2001 | - | $4.38 M(-2.1%) |
| Mar 2001 | - | $4.48 M(+2.1%) |
| Dec 2000 | $4.38 M(+104.8%) | $4.38 M(+22.1%) |
| Sept 2000 | - | $3.59 M(-12.0%) |
| June 2000 | - | $4.08 M(-24.7%) |
| Mar 2000 | - | $5.42 M(+153.3%) |
| Dec 1999 | $2.14 M(-46.3%) | $2.14 M(-10.7%) |
| Sept 1999 | - | $2.40 M(-7.3%) |
| June 1999 | - | $2.59 M(-13.8%) |
| Mar 1999 | - | $3.00 M(-24.8%) |
| Dec 1998 | $3.99 M(+59.7%) | $3.99 M(+4.7%) |
| Sept 1998 | - | $3.81 M(-28.2%) |
| June 1998 | - | $5.30 M(+36.1%) |
| Mar 1998 | - | $3.90 M(+56.0%) |
| Dec 1997 | $2.50 M | $2.50 M(-21.9%) |
| Sept 1997 | - | $3.20 M(-27.3%) |
| June 1997 | - | $4.40 M |
FAQ
- What is Nymox Pharmaceutical annual total assets?
- What is the all time high annual total assets for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly total assets?
- What is the all time high quarterly total assets for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual total assets?
The current annual total assets of NYMX is $1.63 M
What is the all time high annual total assets for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual total assets is $13.50 M
What is Nymox Pharmaceutical quarterly total assets?
The current quarterly total assets of NYMX is $575.00 K
What is the all time high quarterly total assets for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly total assets is $13.50 M